Results 251 to 260 of about 499,883 (421)
Comparison of Corticosteroid and Sulphasalazine Therapy in Ulcerative Colitis [PDF]
S. C. Truelove, G. Watkinson, G J Draper
openalex +1 more source
The aim of this study is to compare oats and rice as the main cereal source of a low‐gluten diet followed by metabolically challenged volunteers. The participants consumed four portions of either oat or rice products daily for 6 weeks and avoided glutinous cereals.
Enni Mannila+9 more
wiley +1 more source
Association of the TNFRSF1B-rs1061622 variant with nonresponse to infliximab in ulcerative colitis. [PDF]
Tessier L+9 more
europepmc +1 more source
This study provides insights into the clinical characteristics and cost burden of pediatric‐onset inflammatory bowel disease (PIBD) and very early onset IBD (VEO‐IBD) in China. Hospitalizations for PIBD, particularly Crohn's disease, are increasing. Guidelines and health insurance policies can help mitigate the cost burden.
Xiaolu Nie+11 more
wiley +1 more source
THE SURGICAL TREATMENT OF INTRACTABLE, CHRONIC ULCERATIVE COLITIS
Henry W. Cave
openalex +2 more sources
Signifiance of autoimmune reactions to pancreatic juice in Crohn´s disease [PDF]
Goebell, Harald+5 more
core +1 more source
Abstract Mirikizumab is a p19‐directed anti‐interleukin‐23 antibody approved for the treatment of adults with moderate‐to‐severe ulcerative colitis (UC). Here, we report the first data of mirikizumab pharmacokinetics (PK) and exposure–response (E/R) relationships in pediatric participants (aged 2 to <18 years weighing >10 kg) with moderate‐to‐severe UC
Yuki Otani+5 more
wiley +1 more source
Radiomics prediction of surgery in ulcerative colitis refractory to medical treatment. [PDF]
Sakamoto K+7 more
europepmc +1 more source
The Understudied Landscape of Hidradenitis Suppurativa in Asian Skin of Colour Populations
JEADV Clinical Practice, EarlyView.
Anju George
wiley +1 more source